Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
In addition, physicians want to be able to track weight loss for patients using injections in real time without the patient making an office visit
Conclusion Currently, there is a large population of NAFLD/NASH patients who require long-term treatment, yet there is only one approved drug specifically for NASH, Rezdiffra (resmetirom), indicating that the clinical need is far from being fully met
Pricing requires a consultation before it becomes visible
In Singapore, Cell, Tissue, or Gene Therapy Products (CTGTP) are regulated by the Health Science Authority (HSA)
may be associated with parenchymal compression
US$ 25.64
US$ 26.68
US$ 21.16
US$ 24.65
